Swedish Orphan Biovitrum AB (Sobi) has appointed Henrik Stenqvist as its chief financial officer, effective in the late spring. Mr Stenqvist will be joining Sobi from Recipharm AB where he is CFO. Before that, he was CFO of the Meda Group where he helped grow the small Nordic company into an international specialty pharma business. Mr Stenqvist holds a degree in finance and business administration from the University of Linköping in Sweden.
Sobi announced the appointment on 26 February 2018.
Copyright 2018 Evernow Publishing Ltd